Brief: VolitionRx Limited Announces Strategic Acquisition
Dec 16 (Reuters) - VolitionRX Ltd VNRX.A :
* VOLITIONRX LIMITED ANNOUNCES STRATEGIC ACQUISITION
* VOLITIONRX LTD - DEAL FOR APPROXIMATELY $725,000
CONSISTING OF
CASH AND SHARES OF RESTRICTED COMMON STOCK OF VOLITION
* VOLITIONRX - DEAL INCLUDES TRANSFER OF STANDARD OPERATING
PROCEDURES AND KEY ASSETS IN ADDITION TO ONSITE TRAINING FOR
BELGIAN VOLITION SCIENTISTS
* VOLITIONRX - IN CONNECTION WITH TRANSACTION, PARTIES WILL
ALSO
ENTER INTO 5-YEAR ROYALTY AGREEMENT
Source text for Eikon: ID:nPn87pBhSa
Further company coverage: VNRX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VolitionRX
See all newsBrief: Volitionrx -Files Preliminary Prospectus For 10,006,360 Shares Of Common Stock Offered By Selling Stockholder - SEC Filing
Brief: Volitionrx - Advances Nu.Q Nets Platform Towards Commercialization
Brief: VolitionRX Limited Announces First Quarter 2026 Financial Results
Brief: Volition Reports Breakthrough In Liquid Biopsy Achievement Of Over 99% Purity In Isolating Cancer Dna
Brief: Volition Announces First Ever Automated Nu.Q® Vet Cancer Test With Fujifilm Vet Systems